Clinical Trial

I-FABP as a Predictor of Gastrointestinal Involvement in Pediatric IgA Vasculitis

Study acronym: IFABP-IgAV
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.
Trial Details
NCT Number NCT07664228
Lead Sponsor Bursa City Hospital
Conditions IgA Vasculitis, Gastrointestinal Involvement
Enrollment 100 participants
Start Date 2026-05-15
Primary Completion 2027-02-15 (estimated)
Study Completion 2027-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-24